SMS Technology for the Promotion of Diabetes Education and Self-Management in Egypt

August 11, 2016 updated by: Haitham Abaza, Hannover Medical School

SMS Technology for the Promotion of Diabetes Education and Self-Management

This study was conducted at the teaching hospital of Misr University for Science & Technology. It aimed to examine the use of SMS technology in educating and monitoring diabetic patients in Egypt, and assess the impact of educational text messages on their glycemic control and self-management behaviors. Participants were randomized into an intervention and a control group. Intervention patients received an instruction booklet as well as daily educational and weekly reminder messages to better control their diabetes. Control patients received the same instruction booklet but no SMS messages. Both group patients took an HbA1c test at the beginning and end of the study period and were asked to measure their blood glucose once a week and record their readings into a monitoring table over 12 weeks. The primary outcome was the change in HbA1c levels, which was expected to be greater among intervention patients at the end of the study. Secondary outcomes included blood glucose levels, treatment and medication adherence, diabetes self-efficacy, rate of hospital/ER visits, frequency of blood glucose measurement, among others.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Cairo
      • Giza, Cairo, Egypt, 12566
        • Misr University for Science & Technology (MUST) hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • has diabetes
  • owns a mobile phone
  • can read SMS messages or lives with someone that can read for them.

Exclusion Criteria:

  • cannot read or not SMS familiar and lives alone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
This group received a diabetes instruction booklet in addition to daily educational SMS messages and weekly reminders
Other: SMS messages

Daily educational messages addressing the following categories: diet, exercise, complications, medications, foot care, blood sugar testing, and hypo- and hyperglycemia.

Weekly reminder messages of blood glucose testing.

Other: Instruction booklet
General detailed instructions addressing the same SMS categories.
Active Comparator: Control group
This group only received a diabetes instruction booklet
Other: Instruction booklet
General detailed instructions addressing the same SMS categories.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in HbA1c
Time Frame: baseline and 12 weeks
measured by the difference between endpoint and baseline values and by the number of patients who experienced a reduction of at least 1% from baseline to endpoint
baseline and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body weight
Time Frame: 12 weeks
12 weeks
blood glucose levels
Time Frame: 12 weeks
12 weeks
Treatment adherence
Time Frame: 12 weeks
measured by the diabetes self-care inventory (SCI)
12 weeks
Medication adherence
Time Frame: 12 weeks
measured by the Morisky medication adherence scale (MMAS-4)
12 weeks
Diabetes self-efficacy
Time Frame: 12 weeks
measured by the diabetes empowerment scale short form (DES-SF)
12 weeks
Frequency of blood glucose measurement
Time Frame: 12 weeks
12 weeks
Rate of hospital/ER admissions
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hannover Medical School

Collaborators

Misr University for Science and Technology

Investigators

  • Principal Investigator: Haitham Abaza, PLRI Institute for Medical Informatics, Hannover Medical School
  • Study Director: Michael Marschollek, PLRI Institute for Medical Informatics, Hannover Medical School

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

August 9, 2016

First Submitted That Met QC Criteria

August 11, 2016

First Posted (Estimate)

August 16, 2016

Study Record Updates

Last Update Posted (Estimate)

August 16, 2016

Last Update Submitted That Met QC Criteria

August 11, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DiabAwPro

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Clinical Trials on SMS messages

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe